Organoids in petri dish
© Gouti Lab /Diecke TP | Felix Petermann, Max Delbrück Center
Science / July 25, 2025

Podcast on mini-organs from the lab

Ines Lahmann explains how organoids could change medical research in a podcast called ‘Forschungsquartett’. Listen to the interview with detektor.fm editor Esther Stephan (in German).

Organoids are tiny replicas of human organs. Instead of animal testing, these mini-organs derived from stem cells could soon help us better understand diseases and develop tailored therapies.

Dr. Ines Lahmann is working with neuromuscular organoids at the Gouti Lab. She says: "What is particularly exciting about our organoids is that they are functional. This means that the muscles start to contract, induced by the nerve cells in the culture."

Listen to the whole interview in the Podcast at detektor.fm

Further information

Ines Lahmann wins Helmholtz Field Study Fellowship

Related news & events

Scientific image

Histological image of multiple myeloma in bone marrow: Degenerated plasma cells are stained purple. The image shows that they have almost completely displaced healthy cells. The large white cavities are artefacts caused by fixation of the tissue sample.

© Ioannis Anagnostopoulos, Institute of Pathology, University of Würzburg
Science

A double-pronged attack on malignant B cells

Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that recognizes two distinct features of malignant cells to destroy the cancer more effectively.
Nikolaus Rajewsky und Leif Sander
© Pablo Castagnola, Max Delbrück Center | Charité, Wiebke Peitz
Science

A new opportunity for Berlin

The Einstein Center for Early Disease Interception has been funded with six million euros. In an interview, Nikolaus Rajewsky and Leif Erik Sander, both spokespeople of the center, explain why new technologies and cross-institutional collaboration will make disease prevention in the future possible.
People talking
© Bettina Ausserhofer, Max Delbrück Center
Science

Bridging science and business

During the Predictive Systems Medicine Partnering Event at the Max Delbrück Center, researchers and industry representatives shared insights and explored commercialization opportunities – advancing our mission to turn discovery into real-world health impact.
Scientific image

T stem cells normally undergo asymmetric cell division (left) whereby one daughter cell becomes a long-lived memory T cell. When autophagy is disrupted, both daughter cells inherit old mitochondria (red) and become effector T-cells.

© University of Oxford
Press Release No. 29

What determines the fate of a T cell?

Researchers at the Max Delbrück Center have found that a cellular housekeeping mechanism called autophagy plays a major role in ensuring that T stem cells undergo normal cell division. The findings, published in “Nature Cell Biology,” could help boost vaccine response in older adults.